KC
IDXX icon

Kingfisher Capital’s Idexx Laboratories IDXX Stock Holding History

Kingfisher Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,760
Closed -$1.08M – 126
2016
Q1 		$1.08M Sell
13,760
-30
-0.2% -$2.16K 0.68% 71
2015
Q4 		$1.01M Buy
+13,790
New +$984K 0.59% 77

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Kingfisher Capital's IDXX Position: Q2 2016 in Review

Kingfisher Capital sold out of Idexx Laboratories (IDXX) in Q2 2016, closing a stake of 13,760 shares — an estimated $1.08M sold.

Kingfisher Capital first reported a position in IDXX in Q4 2015 and held it in 2 quarters. The position peaked at $1.08M in Q1 2016. 438 funds tracked by Wall St. Rank hold IDXX as of Q2 2016.

  • Kingfisher Capital reported no remaining Idexx Laboratories position as of Q2 2016 after selling out during the quarter.
  • Kingfisher Capital sold 13,760 Idexx Laboratories shares in Q2 2016, an estimated $1.08M.
  • Kingfisher Capital first reported a position in Idexx Laboratories in Q4 2015 and held it in 2 quarters.
  • Kingfisher Capital's Idexx Laboratories position peaked at $1.08M in Q1 2016.
  • 438 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2016.

Based on Kingfisher Capital's 13F filing for Q2 2016, filed 15 Aug 2016.